{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d65" }, "patient_id" : "YwSN7SjqLrTcJ4jW7", "patient_label" : "DTB-134", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 69, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-134", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-134Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Goserelin", "start_day" : -2060, "end_day" : -1136, "reason_for_stop" : "Other" }, { "drug_name" : "Bicalutamide", "start_day" : -2060, "end_day" : -2019, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Degarelix", "start_day" : -1134, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -303, "end_day" : -3, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -303, "end_day" : -7, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-134Pro", "drug_name" : "Enzalutamide", "treatment_category" : { "$undefined" : true }, "start_day" : 10, "end_day" : NaN, "on_study" : { "$date" : "2014-12-10T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d66" }, "patient_id" : "E2FKuv7XFLYR6QsFG", "patient_label" : "DTB-135", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 57, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-135", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-135Pro", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -182, "end_day" : -161, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -50, "end_day" : -16, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -175, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-135Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : 76, "on_study" : { "$date" : "2014-12-10T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d67" }, "patient_id" : "Ws2F9sT2CJWsQ7GgZ", "patient_label" : "DTB-149", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 70, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-149", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -183, "end_day" : -79, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -573, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-149", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : NaN, "on_study" : { "$date" : "2015-02-11T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d68" }, "patient_id" : "mhc4BYwQ8bHKCHX8z", "patient_label" : "DTB-150", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "Asian", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-150", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Degarelix", "start_day" : -591, "end_day" : -557, "reason_for_stop" : "Other" }, { "drug_name" : "Zoladex", "start_day" : -536, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -536, "end_day" : -560, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -175, "end_day" : 1, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-150", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2015-02-22T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d69" }, "patient_id" : "QmcW7BKTWg86fTSNs", "patient_label" : "DTB-151", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 72, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-151", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -4446, "end_day" : -793, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -4446, "end_day" : -793, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -216, "end_day" : -216, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -793, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-151", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 14, "end_day" : NaN, "on_study" : { "$date" : "2015-03-04T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d6a" }, "patient_id" : "2BHsjFofkyijh9iRc", "patient_label" : "DTB-153", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 78, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-153", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -7360, "end_day" : NaN, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Zoladex;  Flutamide", "start_day" : -7360, "end_day" : -6629, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -1942, "end_day" : -1516, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "XGEVA", "start_day" : -1243, "end_day" : -1243, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "TAK-700", "start_day" : 18, "end_day" : -1091, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Lupron", "start_day" : -1077, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "XGEVA", "start_day" : -770, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Sipuleucel-T", "start_day" : -362, "end_day" : -335, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Enzalutamide", "start_day" : -331, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-153", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2015-02-24T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d6b" }, "patient_id" : "PR5h2CdRKwT43F4ew", "patient_label" : "DTB-154", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 78, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-154", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -738, "end_day" : -463, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1559, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -1651, "end_day" : -2655, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d6c" }, "patient_id" : "MkKjGQXs5wBF2u3Hy", "patient_label" : "DTB-155", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1102, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -791, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Provenge", "start_day" : NaN, "end_day" : -474, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -264, "end_day" : -281, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -264, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d6d" }, "patient_id" : "bRErqopLjhi8EW98v", "patient_label" : "DTB-156", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-156", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -651, "end_day" : -436, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : NaN, "end_day" : -1, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-156", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 1, "end_day" : NaN, "on_study" : { "$date" : "2015-04-12T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d6e" }, "patient_id" : "mvnYvQ4Xe4MQthWs3", "patient_label" : "DTB-157", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 59, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d6f" }, "patient_id" : "3urrrrJmXJsG7Ao7R", "patient_label" : "DTB-158", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 72, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-158", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -2288, "end_day" : -2107, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1468, "end_day" : -737, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -196, "end_day" : 5, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "XGEVA", "start_day" : -72, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -737, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -2288, "end_day" : -2107, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Placebo;  ARN-509", "start_day" : -359, "end_day" : -245, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-158", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 7, "end_day" : NaN, "on_study" : { "$date" : "2015-04-07T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d70" }, "patient_id" : "CEvjHMJqWhfTuchgf", "patient_label" : "DTB-159", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 79, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-159", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 8, "end_day" : NaN, "on_study" : { "$date" : "2015-04-08T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d71" }, "patient_id" : "RqDwrkkFbfbHd9w5w", "patient_label" : "DTB-160", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 87, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d72" }, "patient_id" : "oDKpdHBSs4LTaykFC", "patient_label" : "DTB-086", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 72, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-086", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -258, "end_day" : 1, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -325, "end_day" : -270, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -806, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-086", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 0, "end_day" : 57, "on_study" : { "$date" : "2014-04-15T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d73" }, "patient_id" : "qfPKdFYw32ow3MSeq", "patient_label" : "DTB-088", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 73, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-088", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : NaN, "end_day" : -30, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -837, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-088", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : 89, "on_study" : { "$date" : "2014-04-16T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d74" }, "patient_id" : "nAq2SYn5pgHuQZpNw", "patient_label" : "DTB-089", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 79, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-089", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKD1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-089Pro", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -996, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -837, "end_day" : -548, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -548, "end_day" : -27, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -2625, "end_day" : -2576, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1661, "end_day" : -1416, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1689, "end_day" : -1416, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Dutasteride", "start_day" : -1388, "end_day" : -1016, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1010, "end_day" : -990, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-089Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 7, "end_day" : 89, "on_study" : { "$date" : "2014-04-16T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d75" }, "patient_id" : "KzgNEkHYrJWujQYJD", "patient_label" : "DTB-090", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 45, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-090", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-090", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 7, "end_day" : 149, "on_study" : { "$date" : "2014-05-04T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PR", "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-090", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : -209, "end_day" : 260, "on_study" : { "$date" : "2014-05-04T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d76" }, "patient_id" : "Q3MFPFwKPft7btvAA", "patient_label" : "DTB-091", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 79, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-091", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Degarelix", "start_day" : -325, "end_day" : -269, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Bicalutamide", "start_day" : -150, "end_day" : -52, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -241, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-091", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : 81, "on_study" : { "$date" : "2014-05-08T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d77" }, "patient_id" : "tCP4iD7z6EFbKhZLw", "patient_label" : "DTB-097", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 73, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-097", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-097Pro", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1353, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -179, "end_day" : -117, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -1366, "end_day" : -1366, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Abiraterone", "start_day" : -30, "end_day" : 5, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -96, "end_day" : 5, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-097Pro", "drug_name" : "BMN-673", "treatment_category" : "Clinical Trial", "start_day" : 13, "end_day" : 239, "on_study" : { "$date" : "2014-05-28T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d78" }, "patient_id" : "N6mtX5JkEHfBmzhZP", "patient_label" : "DTB-101", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 74, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-101", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -2647, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -2360, "end_day" : -2367, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -2450, "end_day" : -2459, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1881, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1789, "end_day" : -2001, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel;  Carboplatin", "start_day" : -1702, "end_day" : -1576, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Abiraterone", "start_day" : -747, "end_day" : 58, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Carboplatin;  Docetaxel", "start_day" : -1282, "end_day" : -1154, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel;  Carboplatin", "start_day" : -1499, "end_day" : -1331, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-101", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 148, "end_day" : 287, "on_study" : { "$date" : "2014-06-24T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-101", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 91, "end_day" : 135, "on_study" : { "$date" : "2014-06-24T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d79" }, "patient_id" : "6nHuWKgiM6q7XrwRY", "patient_label" : "DTB-103", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-103", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-103Pro", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2225, "end_day" : -2205, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1280, "end_day" : -1141, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1119, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -3095, "end_day" : -2730, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-103Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 9, "end_day" : 161, "on_study" : { "$date" : "2014-06-22T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d7a" }, "patient_id" : "FD4senrxLM7nfD85r", "patient_label" : "DTB-105", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-105", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-105Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -4624, "end_day" : -4259, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -893, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -914, "end_day" : -679, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -3764, "end_day" : -3436, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -3800, "end_day" : -3436, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -4532, "end_day" : -4624, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -305, "end_day" : 1, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Cabazitaxel;  Mitoxantrone", "start_day" : -571, "end_day" : -376, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-105Pro", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 15, "end_day" : 71, "on_study" : { "$date" : "2014-06-29T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-105Pro", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 130, "end_day" : 154, "on_study" : { "$date" : "2014-06-29T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d7b" }, "patient_id" : "ySjnWFKPerxous9QT", "patient_label" : "DTB-108", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-108", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "start_day" : -141, "end_day" : 55, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -495, "end_day" : -141, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron;  Casodex", "start_day" : -1530, "end_day" : -768, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron;  Casodex", "start_day" : -2276, "end_day" : -2168, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Provenge", "start_day" : -579, "end_day" : -538, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -495, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-108", "drug_name" : { "$undefined" : true }, "treatment_category" : "SOC", "start_day" : 92, "end_day" : 140, "on_study" : { "$date" : "2014-07-08T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-108", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 160, "end_day" : 223, "on_study" : { "$date" : "2014-07-08T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Physician Discretion" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d7c" }, "patient_id" : "gRGvTx6Rz2xfcBRx4", "patient_label" : "DTB-109", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-109", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -502, "end_day" : 1, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1323, "end_day" : -806, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1323, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Taxotere", "start_day" : -615, "end_day" : -502, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -615, "end_day" : 10, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-109", "drug_name" : "Sipuleucel-T", "treatment_category" : "SOC", "start_day" : 8, "end_day" : 51, "on_study" : { "$date" : "2014-07-15T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d7d" }, "patient_id" : "iZBe5MQQJrb9gEgWo", "patient_label" : "DTB-110", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 66, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-110", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1657, "end_day" : -927, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -183, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -47, "end_day" : -357, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -777, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Finasteride", "start_day" : -1657, "end_day" : NaN, "reason_for_stop" : "Other" }, { "sample_label" : "DTB-110", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-07-15T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d7e" }, "patient_id" : "BgtMJnZQwG8vjyhSK", "patient_label" : "DTB-111", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 69, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-111", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-111Pro", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -2075, "end_day" : -1893, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Lupron", "start_day" : -1403, "end_day" : -1204, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -1403, "end_day" : -1114, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -938, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -780, "end_day" : -751, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -938, "end_day" : -850, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Casodex;  Panobinostat", "start_day" : -696, "end_day" : -464, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -408, "end_day" : -16, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-111Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : 138, "on_study" : { "$date" : "2014-08-06T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d7f" }, "patient_id" : "3zLuQWirS2HYxvkgB", "patient_label" : "DTB-112", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 76, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-112", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -4343, "end_day" : -3975, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "start_day" : -4350, "end_day" : -4323, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Leuprolide", "start_day" : -3751, "end_day" : -2950, "reason_for_stop" : "Other" }, { "drug_name" : "Flutamide", "start_day" : -3421, "end_day" : -3239, "reason_for_stop" : "Other" }, { "drug_name" : "Nilutamide", "start_day" : -2279, "end_day" : -2118, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -2328, "end_day" : -2279, "reason_for_stop" : "Other" }, { "drug_name" : "Bicalutamide", "start_day" : -3238, "end_day" : -2426, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -2076, "end_day" : -109, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Pazopanib", "start_day" : -2076, "end_day" : -474, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -334, "end_day" : 10, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -2866, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-112", "drug_name" : "Enzalutamide", "treatment_category" : { "$undefined" : true }, "start_day" : 21, "end_day" : NaN, "on_study" : { "$date" : "2014-08-10T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d80" }, "patient_id" : "Am48cg6RKzRhiwDFB", "patient_label" : "DTB-113", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 70, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "sample_label" : "DTB-113", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : -183, "end_day" : 211, "on_study" : { "$date" : "2014-08-11T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d81" }, "patient_id" : "pj5vhx2fCMmfPbbqB", "patient_label" : "DTB-114", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 76, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "treatments" : [ { "sample_label" : "DTB-114", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 13, "end_day" : 94, "on_study" : { "$date" : "2014-08-18T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Patient Demise" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d82" }, "patient_id" : "c9t8tDCZ7kCRckxdr", "patient_label" : "DTB-115", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 61, "race" : "American Indian or Alaska Native", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-115", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -190, "end_day" : -93, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -574, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-115", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 19, "end_day" : NaN, "on_study" : { "$date" : "2014-08-20T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d83" }, "patient_id" : "uoXwMt28nCbSqL7iE", "patient_label" : "DTB-116", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 68, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-116", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-116", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 21, "end_day" : 126, "on_study" : { "$date" : "2014-09-08T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d84" }, "patient_id" : "EQkr63NbgTgS5vZkA", "patient_label" : "DTB-117", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 82, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-117", "site_of_metastasis" : "Lung", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -1288, "end_day" : -1111, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Sipuleucel-T", "start_day" : -985, "end_day" : -957, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "ARN-509", "start_day" : -866, "end_day" : -369, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Abiraterone", "start_day" : -278, "end_day" : -173, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "GM-CSF", "start_day" : -172, "end_day" : -12, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1111, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-117", "drug_name" : "Docetaxel;  Dexamethasone", "treatment_category" : "SOC", "start_day" : 2, "end_day" : 44, "on_study" : { "$date" : "2014-09-08T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-117", "drug_name" : "Dexamethasone", "treatment_category" : "SOC", "start_day" : 53, "end_day" : NaN, "on_study" : { "$date" : "2014-09-08T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d85" }, "patient_id" : "ftK8ZKrsLZH6gD6Bt", "patient_label" : "DTB-118", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 73, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-118", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATR_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "GSK3A_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -254, "end_day" : -1090, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1350, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -1029, "end_day" : -877, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Enzalutamide", "start_day" : -595, "end_day" : -86, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Buparlisib", "start_day" : -196, "end_day" : -86, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -86, "end_day" : -24, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-118", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 18, "end_day" : 61, "on_study" : { "$date" : "2014-09-24T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d86" }, "patient_id" : "NzweJdJ6xSuNHfRXs", "patient_label" : "DTB-119", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-119", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-119", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 52, "end_day" : NaN, "on_study" : { "$date" : "2014-09-09T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d87" }, "patient_id" : "br4EXcDLYstZEAJf2", "patient_label" : "DTB-120", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 64, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-120", "site_of_metastasis" : "Lung", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -395, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -419, "end_day" : -42, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-120", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-10-05T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d88" }, "patient_id" : "6gXJ4qbbaHLKttfvw", "patient_label" : "DTB-121", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 90, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-121", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA5_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "start_day" : -158, "end_day" : 42, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -735, "end_day" : -247, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -9409, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-121", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-10-05T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d89" }, "patient_id" : "P4dHkzdLafXykHETS", "patient_label" : "DTB-122", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 72, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-122", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex", "start_day" : -1857, "end_day" : -1718, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -207, "end_day" : 5, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -350, "end_day" : -262, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -681, "end_day" : -350, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron Depot", "start_day" : -795, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron Depot", "start_day" : -1659, "end_day" : -1143, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Casodex", "start_day" : -1804, "end_day" : -1642, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-122", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 5, "end_day" : 108, "on_study" : { "$date" : "2014-10-09T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-122", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 115, "end_day" : NaN, "on_study" : { "$date" : "2014-10-09T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d8a" }, "patient_id" : "zm2ZgmJuqrHYdycEv", "patient_label" : "DTB-123", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 88, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-123", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -6545, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -670, "end_day" : -32, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Sipuleucel-T", "start_day" : -367, "end_day" : -321, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-123", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 9, "end_day" : NaN, "on_study" : { "$date" : "2014-12-02T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d8b" }, "patient_id" : "fqrsxDMxJJhLGgDDd", "patient_label" : "DTB-124", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 74, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-124", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA5_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Goserelin", "start_day" : -391, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -398, "end_day" : -165, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Degarelix", "start_day" : -763, "end_day" : -763, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Flutamide", "start_day" : -4883, "end_day" : -4820, "reason_for_stop" : "Adverse Event" }, { "drug_name" : { "$undefined" : true }, "start_day" : -5002, "end_day" : -398, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : { "$undefined" : true }, "start_day" : -5009, "end_day" : -241, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Enzalutamide", "start_day" : -131, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-124", "drug_name" : "Docetaxel", "treatment_category" : { "$undefined" : true }, "start_day" : 42, "end_day" : 169, "on_study" : { "$date" : "2014-10-26T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d8c" }, "patient_id" : "39tQqGZZecXpcrNdD", "patient_label" : "DTB-125", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 65, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-125", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -5785, "end_day" : -5785, "reason_for_stop" : "Other" }, { "drug_name" : { "$undefined" : true }, "start_day" : -5729, "end_day" : -5729, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -82, "end_day" : -2, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Zoladex", "start_day" : -5785, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-125", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-11-02T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d8d" }, "patient_id" : "xt8hzcPTKa3xzBiKY", "patient_label" : "DTB-126", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 90, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-126", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -62, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -62, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -283, "end_day" : -62, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -516, "end_day" : -488, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -516, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -6703, "end_day" : -6703, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-126", "drug_name" : { "$undefined" : true }, "treatment_category" : "SOC", "start_day" : -6703, "end_day" : -6703, "on_study" : { "$date" : "2014-12-22T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-126", "drug_name" : "Lupron", "treatment_category" : "SOC", "start_day" : -516, "end_day" : NaN, "on_study" : { "$date" : "2014-12-22T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-126", "drug_name" : "Casodex", "treatment_category" : "SOC", "start_day" : -516, "end_day" : -488, "on_study" : { "$date" : "2014-12-22T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-126", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : -283, "end_day" : -62, "on_study" : { "$date" : "2014-12-22T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-126", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : -62, "end_day" : NaN, "on_study" : { "$date" : "2014-12-22T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d8e" }, "patient_id" : "X28WFs9k76jB4WtPt", "patient_label" : "DTB-127", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 72, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-127", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : NaN, "end_day" : -640, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -640, "end_day" : -469, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -168, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -265, "end_day" : -168, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Zoladex", "start_day" : -1202, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1540, "end_day" : -1301, "reason_for_stop" : "Other" }, { "drug_name" : "Lupron", "start_day" : -2620, "end_day" : -2132, "reason_for_stop" : "Other" }, { "sample_label" : "DTB-127", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 1, "end_day" : 15, "on_study" : { "$date" : "2014-11-02T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Other" }, { "sample_label" : "DTB-127", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 91, "end_day" : NaN, "on_study" : { "$date" : "2014-11-02T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d8f" }, "patient_id" : "AReSwk7qAoJf7cPvg", "patient_label" : "DTB-128", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 78, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-128", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -265, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -273, "end_day" : -84, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-128", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : NaN, "on_study" : { "$date" : "2014-11-05T16:00:00.000-0800" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d90" }, "patient_id" : "tdRECCPeJXeDHEuts", "patient_label" : "DTB-129", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-129", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2872, "end_day" : -2872, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Degarelix", "start_day" : -470, "end_day" : -441, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -441, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-129", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : NaN, "on_study" : { "$date" : "2014-11-11T16:00:00.000-0800" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d91" }, "patient_id" : "Buoz57wSPa8J7aaaJ", "patient_label" : "DTB-130", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 65, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-130", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Provenge", "start_day" : -131, "end_day" : -117, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron;  Casodex", "start_day" : -2232, "end_day" : -352, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -3526, "end_day" : -2819, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -105, "end_day" : 1, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -105, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-130", "drug_name" : "Fluorouracil; Leucovorin; Oxaliplatin (FOLFOX)", "treatment_category" : "SOC", "start_day" : 27, "end_day" : NaN, "on_study" : { "$date" : "2014-11-17T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-130", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 122, "end_day" : 153, "on_study" : { "$date" : "2014-11-17T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d92" }, "patient_id" : "SAKEKwAHRGfGFx7nw", "patient_label" : "DTB-131", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 63, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "sample_label" : "DTB-131", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 0, "end_day" : NaN, "on_study" : { "$date" : "2014-11-18T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d93" }, "patient_id" : "QcoyHbE9r5xyqYnfo", "patient_label" : "DTB-132", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 83, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-132", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2512, "end_day" : -2421, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -2526, "end_day" : -2469, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -255, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -1722, "end_day" : -1501, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-132", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 2, "end_day" : NaN, "on_study" : { "$date" : "2014-11-16T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d94" }, "patient_id" : "cdjpiYgitsH5efEAQ", "patient_label" : "DTB-133", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 65, "race" : "White; Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-133", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -102, "end_day" : -20, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Xofigo", "start_day" : -246, "end_day" : -106, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -604, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -725, "end_day" : -124, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Abiraterone", "start_day" : -986, "end_day" : -2, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Sipuleucel-T", "start_day" : -1128, "end_day" : -1098, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1251, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -1401, "end_day" : -1251, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -1828, "end_day" : -1401, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Cyclophosphamide;  GM-CSF", "start_day" : -2193, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -2376, "end_day" : -2376, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Dutasteride;  Bicalutamide;  Lupron", "start_day" : -2528, "end_day" : -2193, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-133", "drug_name" : "Selinexor", "treatment_category" : "Clinical Trial", "start_day" : 34, "end_day" : NaN, "on_study" : { "$date" : "2014-12-02T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d95" }, "patient_id" : "sJp9QJsh8XLcuagrz", "patient_label" : "DTB-136", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 79, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "sample_label" : "DTB-136", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : -116, "end_day" : NaN, "on_study" : { "$date" : "2014-12-15T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d96" }, "patient_id" : "C9CKfnSaPuRgdD6g3", "patient_label" : "DTB-137", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 61, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-137", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Degarelix", "start_day" : -328, "end_day" : -299, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -306, "end_day" : -292, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron Depot", "start_day" : -299, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-137", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 13, "end_day" : NaN, "on_study" : { "$date" : "2014-12-16T16:00:00.000-0800" }, "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d97" }, "patient_id" : "MyJCqb6JueS4NKj5p", "patient_label" : "DTB-138", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 78, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-138", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Leuprolide", "start_day" : -2483, "end_day" : -2124, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Bicalutamide", "start_day" : -2483, "end_day" : -2124, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Zoladex", "start_day" : -1215, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -934, "end_day" : -468, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Flutamide", "start_day" : -419, "end_day" : -376, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -376, "end_day" : -335, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -257, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-138", "drug_name" : "Docetaxel", "treatment_category" : { "$undefined" : true }, "start_day" : 11, "end_day" : NaN, "on_study" : { "$date" : "2014-12-28T16:00:00.000-0800" }, "psa_response" : ">90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d98" }, "patient_id" : "nHKERprwLJHDsoWds", "patient_label" : "DTB-139", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 68, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-139", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -320, "end_day" : 13, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -1104, "end_day" : -321, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Zoladex", "start_day" : -1315, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1434, "end_day" : -1104, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Leuprolide", "start_day" : -1419, "end_day" : -1315, "reason_for_stop" : "Other" }, { "sample_label" : "DTB-139", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 13, "end_day" : NaN, "on_study" : { "$date" : "2015-01-13T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d99" }, "patient_id" : "5p4wCcHtETzjWCAY6", "patient_label" : "DTB-141", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-141", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -1012, "end_day" : -99, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1012, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-141", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : NaN, "on_study" : { "$date" : "2015-01-07T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d9a" }, "patient_id" : "QC6PSo8H4R8qHMBrK", "patient_label" : "DTB-142", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "sample_label" : "DTB-142", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : -194, "end_day" : NaN, "on_study" : { "$date" : "2015-01-26T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d9b" }, "patient_id" : "u2qiZYmHtajEBdzyP", "patient_label" : "DTB-143", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 64, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-143", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -2146, "end_day" : -1355, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -519, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-143", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 12, "end_day" : NaN, "on_study" : { "$date" : "2015-01-14T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d9c" }, "patient_id" : "nH4GjX64fbTvHhRer", "patient_label" : "DTB-144", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "Asian", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-144", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "sample_label" : "DTB-144", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 52, "end_day" : NaN, "on_study" : { "$date" : "2015-02-02T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d9d" }, "patient_id" : "tFMnShcrreCyjHvF5", "patient_label" : "DTB-145", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 70, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-145", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Flutamide", "start_day" : -498, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -142, "end_day" : -8, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -270, "end_day" : -142, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Leuprolide", "start_day" : -498, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -142, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-145", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2015-02-03T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d9e" }, "patient_id" : "WWLrs6hxsvkqE2HqW", "patient_label" : "DTB-146", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 60, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-146", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -1515, "end_day" : -1004, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1544, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -925, "end_day" : -745, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Sipuleucel-T", "start_day" : -918, "end_day" : -890, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -676, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Finasteride", "start_day" : NaN, "end_day" : -1254, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -707, "end_day" : -660, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-146", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 54, "end_day" : NaN, "on_study" : { "$date" : "2015-02-05T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011d9f" }, "patient_id" : "Fmt2uHGWcnyvNRgkK", "patient_label" : "DTB-147", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 62, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-147", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "start_day" : -267, "end_day" : -2, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -531, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -531, "end_day" : -395, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Sipuleucel-T", "start_day" : -332, "end_day" : -304, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-147", "drug_name" : "Cabazitaxel;  Mitoxantrone", "treatment_category" : "Clinical Trial", "start_day" : 60, "end_day" : NaN, "on_study" : { "$date" : "2015-02-11T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da0" }, "patient_id" : "o6fybu3hruLCTuu23", "patient_label" : "DTB-148", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-148", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1546, "end_day" : -1324, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -1560, "end_day" : -1512, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -187, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-148", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 2, "end_day" : NaN, "on_study" : { "$date" : "2015-02-09T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da1" }, "patient_id" : "Z5tTFTDLMo3TRuPB5", "patient_label" : "DTB-003", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-003", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -3705, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -3705, "end_day" : -3096, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -2762, "end_day" : 7, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-003", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 31, "end_day" : 77, "on_study" : { "$date" : "2013-02-21T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da2" }, "patient_id" : "CPzXNDq73uMeMzDMy", "patient_label" : "DTB-004", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 71, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-004", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA5_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -5201, "end_day" : -2644, "reason_for_stop" : "Other" }, { "drug_name" : "Lupron", "start_day" : -2490, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -5201, "end_day" : -4714, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "GM-CSF;  Hydrocortisone Sodium Succinate;  Ketoconazole", "start_day" : -3099, "end_day" : -2644, "reason_for_stop" : "Patient Choice" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1903, "end_day" : -1903, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -2245, "end_day" : -725, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -645, "end_day" : -607, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -538, "end_day" : -386, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -320, "end_day" : -264, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -4714, "end_day" : -3192, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-004", "drug_name" : "Docetaxel;  Carboplatin", "treatment_category" : "SOC", "start_day" : 6, "end_day" : 239, "on_study" : { "$date" : "2013-02-25T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da3" }, "patient_id" : "NyffqNr6MoG57McXe", "patient_label" : "DTB-005", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 60, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-005", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -205, "end_day" : -121, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -121, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -121, "end_day" : -58, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -23, "end_day" : -10, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-005", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 5, "end_day" : 115, "on_study" : { "$date" : "2013-03-14T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-005", "drug_name" : "Carboplatin;  Docetaxel", "treatment_category" : "SOC", "start_day" : 115, "end_day" : 136, "on_study" : { "$date" : "2013-03-14T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da4" }, "patient_id" : "ttBnYyQLwbuLNqPKy", "patient_label" : "DTB-007", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-007", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -110, "end_day" : -12, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -268, "end_day" : -200, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -756, "end_day" : -199, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -756, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-007", "drug_name" : "Cabazitaxel;  Mitoxantrone", "treatment_category" : "Clinical Trial", "start_day" : 37, "end_day" : 142, "on_study" : { "$date" : "2013-03-25T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da5" }, "patient_id" : "N66cijR8e7d7Gw5cJ", "patient_label" : "DTB-008", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-008", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -366, "end_day" : -173, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-008", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 8, "end_day" : 344, "on_study" : { "$date" : "2013-04-01T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-008", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 8, "end_day" : 427, "on_study" : { "$date" : "2013-04-01T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da6" }, "patient_id" : "tkLdgeoXpvwQxFxHP", "patient_label" : "DTB-009", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-009", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AURKB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -399, "end_day" : -134, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -368, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -107, "end_day" : 34, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-009", "drug_name" : "Dexamethasone;  Docetaxel", "treatment_category" : "SOC", "start_day" : 75, "end_day" : 139, "on_study" : { "$date" : "2013-04-09T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-009", "drug_name" : "Dexamethasone;  Docetaxel;  Carboplatin", "treatment_category" : "SOC", "start_day" : 160, "end_day" : 181, "on_study" : { "$date" : "2013-04-09T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da7" }, "patient_id" : "dCjDAFjed5qQGpdgJ", "patient_label" : "DTB-010", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-010", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-010Pro", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-010Pro", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : 66, "on_study" : { "$date" : "2013-04-22T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da8" }, "patient_id" : "iXCR6nvxeZxnwCkQE", "patient_label" : "DTB-011", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 68, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-011", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1204, "end_day" : -139, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1730, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-011", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 11, "end_day" : NaN, "on_study" : { "$date" : "2013-04-18T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011da9" }, "patient_id" : "z2jzHYCDCDGaX9aHT", "patient_label" : "DTB-013", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 65, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-013", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1009, "end_day" : -228, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron Depot", "start_day" : -2682, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Provenge", "start_day" : -228, "end_day" : -200, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex;  Panobinostat", "start_day" : -146, "end_day" : -126, "reason_for_stop" : "Other" }, { "sample_label" : "DTB-013", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 1, "end_day" : NaN, "on_study" : { "$date" : "2013-05-05T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011daa" }, "patient_id" : "tEkM2t9Xp7ZPdnCHy", "patient_label" : "DTB-014", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 65, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-014", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-014Pro", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1346, "end_day" : -403, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -99, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -233, "end_day" : -99, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-014Pro", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : 513, "on_study" : { "$date" : "2013-05-08T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dab" }, "patient_id" : "Fjiymw5jW4fz8fAn9", "patient_label" : "DTB-015", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 74, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-015", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -826, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -826, "end_day" : -465, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -339, "end_day" : -255, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -200, "end_day" : -165, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-015", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 12, "end_day" : 151, "on_study" : { "$date" : "2013-05-16T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dac" }, "patient_id" : "EEpLEoAKPfhrq4EEW", "patient_label" : "DTB-016", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 69, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-016", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-016Pro", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -464, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -472, "end_day" : -443, "reason_for_stop" : "Other" }, { "drug_name" : "Ipilimumab", "start_day" : -254, "end_day" : -212, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-016Pro", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 12, "end_day" : 334, "on_study" : { "$date" : "2013-05-22T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dad" }, "patient_id" : "vKoSMRbpbEKWmvTDX", "patient_label" : "DTB-018", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 55, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-018", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "LCK_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "IKBKB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Nilutamide", "start_day" : -1628, "end_day" : -1232, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1994, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1994, "end_day" : -1628, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1166, "end_day" : -495, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-018", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : -3, "end_day" : 282, "on_study" : { "$date" : "2013-06-16T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dae" }, "patient_id" : "ETsaTSuLfbwXt4LXj", "patient_label" : "DTB-019", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-019", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-019Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -559, "end_day" : -321, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Sipuleucel-T", "start_day" : -280, "end_day" : -249, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Nilutamide", "start_day" : -229, "end_day" : -74, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-019Pro", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 0, "end_day" : 168, "on_study" : { "$date" : "2013-06-17T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011daf" }, "patient_id" : "Zc6gzmNF2e64kAHym", "patient_label" : "DTB-020", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 70, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-020", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKD1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1145, "end_day" : -560, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1145, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Provenge", "start_day" : -464, "end_day" : -436, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Nilutamide", "start_day" : -511, "end_day" : -259, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -259, "end_day" : -160, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -259, "end_day" : -160, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "NRX 194204", "start_day" : -160, "end_day" : -91, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -79, "end_day" : -4, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-020", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : 0, "end_day" : NaN, "on_study" : { "$date" : "2013-06-18T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db0" }, "patient_id" : "WpkQr8GzNz7QTZggk", "patient_label" : "DTB-021", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 57, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-021", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1605, "end_day" : -74, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-021", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 0, "end_day" : 531, "on_study" : { "$date" : "2013-06-25T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db1" }, "patient_id" : "g3uhZCvDD2H7u5Htz", "patient_label" : "DTB-022", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 69, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-022", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PDPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "LCK_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-022Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -345, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ipilimumab", "start_day" : -93, "end_day" : -30, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-022Pro", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : 607, "on_study" : { "$date" : "2013-06-19T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-022Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 622, "end_day" : NaN, "on_study" : { "$date" : "2013-06-19T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db2" }, "patient_id" : "hKFZqgzxevZBNuDup", "patient_label" : "DTB-023", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 54, "race" : "Asian", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-023", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATR_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHEK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -1639, "end_day" : -871, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -871, "end_day" : -666, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -605, "end_day" : -605, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Provenge", "start_day" : -617, "end_day" : -575, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -850, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ketoconazole", "start_day" : -548, "end_day" : -373, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -373, "end_day" : -544, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -263, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -256, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Provenge", "start_day" : -178, "end_day" : -178, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-023", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 34, "end_day" : NaN, "on_study" : { "$date" : "2013-06-27T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db3" }, "patient_id" : "M74vEeYML494mthTi", "patient_label" : "DTB-024", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 77, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-024", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-024Pro", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHUK_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-024Pro2", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "IKBKB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHUK_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -731, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -706, "end_day" : -700, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Panobinostat", "start_day" : -286, "end_day" : -139, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -132, "end_day" : -13, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-024Pro2", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 17, "end_day" : 91, "on_study" : { "$date" : "2013-06-30T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-024Pro2", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 107, "end_day" : 267, "on_study" : { "$date" : "2013-06-30T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db4" }, "patient_id" : "4pKGzu8ycx3GbvT5x", "patient_label" : "DTB-025", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 74, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "treatments" : [ { "drug_name" : "Casodex", "start_day" : -6737, "end_day" : -6119, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Casodex", "start_day" : -5641, "end_day" : -3115, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Lupron", "start_day" : -2476, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -1745, "end_day" : -1684, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -1684, "end_day" : -1472, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Placebo", "start_day" : -1199, "end_day" : -1077, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Hydrocortisone Sodium Succinate;  Ketoconazole", "start_day" : -1077, "end_day" : -376, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -376, "end_day" : -254, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -223, "end_day" : -11, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db5" }, "patient_id" : "iFCbQAFmYShpWFjfK", "patient_label" : "DTB-026", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-026", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-026Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -319, "end_day" : -306, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron;  Casodex", "start_day" : -630, "end_day" : -438, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -342, "end_day" : 49, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -438, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-026Pro", "drug_name" : "Cabazitaxel;  Dexamethasone;  Mitoxantrone", "treatment_category" : "Clinical Trial", "start_day" : 86, "end_day" : 401, "on_study" : { "$date" : "2013-07-08T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db6" }, "patient_id" : "oPGySrspCMnqYqDQw", "patient_label" : "DTB-027", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 72, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-027", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Leuprolide", "start_day" : -831, "end_day" : -305, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -273, "end_day" : -140, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "NRX 194204", "start_day" : -112, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -845, "end_day" : -305, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-027", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 30, "end_day" : 386, "on_study" : { "$date" : "2013-07-16T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db7" }, "patient_id" : "8Kd5rYwj8jyGcE27x", "patient_label" : "DTB-028", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 61, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -3029, "end_day" : -2907, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -3029, "end_day" : -7, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -1507, "end_day" : -1173, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -1173, "end_day" : -1112, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Carboplatin; Etoposide", "start_day" : -897, "end_day" : -777, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -777, "end_day" : -280, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -280, "end_day" : -98, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Taxotere", "start_day" : -98, "end_day" : -7, "reason_for_stop" : "Patient Choice" }, { "sample_label" : "DTB-028", "drug_name" : "Radium-223 chloride", "treatment_category" : "SOC", "start_day" : 16, "end_day" : 16, "on_study" : { "$date" : "2013-07-16T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Physician Discretion" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db8" }, "patient_id" : "c6s67vGqTtPM8BNBQ", "patient_label" : "DTB-030", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-030", "site_of_metastasis" : "Lung", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK5_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MTOR_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AURKB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -2530, "end_day" : -2169, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Carboplatin;  Taxotere", "start_day" : -2118, "end_day" : -1950, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1677, "end_day" : -1496, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Carboplatin;  Taxotere", "start_day" : -1192, "end_day" : -338, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -783, "end_day" : -6, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-030", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 121, "end_day" : NaN, "on_study" : { "$date" : "2013-08-04T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011db9" }, "patient_id" : "jxQXgykSEuSmxGgmX", "patient_label" : "DTB-031", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 49, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-031", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -514, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Panobinostat", "start_day" : -178, "end_day" : -157, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Casodex", "start_day" : -178, "end_day" : -58, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-031", "drug_name" : "MLN8237;  Docetaxel", "treatment_category" : { "$undefined" : true }, "start_day" : 5, "end_day" : 26, "on_study" : { "$date" : "2013-08-08T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dba" }, "patient_id" : "4CH8qaxxR6a9yNkP7", "patient_label" : "DTB-032", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 77, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-032", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "HIPK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "STK11_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1162, "end_day" : -842, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1155, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ipilimumab;  Placebo", "start_day" : -732, "end_day" : -656, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Provenge", "start_day" : -382, "end_day" : -354, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Ketoconazole", "start_day" : -294, "end_day" : -251, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -236, "end_day" : -91, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-032", "drug_name" : "Docetaxel", "treatment_category" : "Clinical Trial", "start_day" : 8, "end_day" : 119, "on_study" : { "$date" : "2013-08-19T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dbb" }, "patient_id" : "p8wF7BfPEcAJpyCDF", "patient_label" : "DTB-033", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 84, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-033", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-033Pro", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -8638, "end_day" : NaN, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Flutamide;  Lupron", "start_day" : -6812, "end_day" : -6478, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Casodex;  Lupron", "start_day" : -6478, "end_day" : -3890, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : -3159, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1698, "end_day" : -1190, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -1182, "end_day" : -999, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -968, "end_day" : -664, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Sipuleucel-T", "start_day" : -634, "end_day" : -572, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -543, "end_day" : -298, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -268, "end_day" : -117, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Cabazitaxel", "start_day" : -69, "end_day" : -47, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-033Pro", "drug_name" : { "$undefined" : true }, "treatment_category" : "Clinical Trial", "start_day" : -69, "end_day" : 134, "on_study" : { "$date" : "2013-08-25T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Patient Choice" }, { "sample_label" : "DTB-033Pro", "drug_name" : "Decadron;  Cytoxan", "treatment_category" : "SOC", "start_day" : 9, "end_day" : 134, "on_study" : { "$date" : "2013-08-25T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-033Pro", "drug_name" : "Radium-223 chloride", "treatment_category" : "SOC", "start_day" : 135, "end_day" : 247, "on_study" : { "$date" : "2013-08-25T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-033Pro", "drug_name" : "Mitoxantrone", "treatment_category" : "SOC", "start_day" : 343, "end_day" : 403, "on_study" : { "$date" : "2013-08-25T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Adverse Event" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dbc" }, "patient_id" : "koMFqKAPN7ZGuQynX", "patient_label" : "DTB-034", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 69, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-034", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PDPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -3260, "end_day" : -3225, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -3211, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -2528, "end_day" : -2096, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilandron", "start_day" : -2042, "end_day" : -1910, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Casodex", "start_day" : -1910, "end_day" : -1832, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ketoconazole", "start_day" : -1724, "end_day" : -1462, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Cabozantinib", "start_day" : -1062, "end_day" : -890, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Ketoconazole", "start_day" : -854, "end_day" : -230, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -62, "end_day" : -12, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-034", "drug_name" : "Docetaxel;  Carboplatin", "treatment_category" : "SOC", "start_day" : 2, "end_day" : 44, "on_study" : { "$date" : "2013-08-26T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dbd" }, "patient_id" : "D5XKmsgz65ntMTDJo", "patient_label" : "DTB-035", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 88, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-035", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "LYN_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex", "start_day" : -3154, "end_day" : -1328, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Leuprolide", "start_day" : -1328, "end_day" : -293, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -432, "end_day" : -37, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -293, "end_day" : 13, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-035", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 8, "end_day" : NaN, "on_study" : { "$date" : "2013-08-20T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dbe" }, "patient_id" : "EPaQdoyK88YEyQqvd", "patient_label" : "DTB-036", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 74, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-036", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AURKA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHEK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1335, "end_day" : 4, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -476, "end_day" : -231, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Abiraterone", "start_day" : -180, "end_day" : 21, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-036", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2013-08-27T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dbf" }, "patient_id" : "xfuTmCvXLxYen8oRQ", "patient_label" : "DTB-037", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 64, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-037", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -2596, "end_day" : -1505, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -2585, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -1435, "end_day" : -1043, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -1043, "end_day" : -924, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -784, "end_day" : -747, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -735, "end_day" : -735, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Taxotere", "start_day" : -672, "end_day" : -462, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -1289, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -339, "end_day" : -247, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-037", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 25, "end_day" : 109, "on_study" : { "$date" : "2013-09-04T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc0" }, "patient_id" : "yp9fWdsiN7squqRp2", "patient_label" : "DTB-038", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 77, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-038", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "GSK3A_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCD_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -2442, "end_day" : -2144, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Zoladex", "start_day" : -2256, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Cixutumumab", "start_day" : -2080, "end_day" : -16, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Flutamide", "start_day" : -3162, "end_day" : -2797, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Nilandron", "start_day" : -2797, "end_day" : -2797, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Estrogen", "start_day" : -11563, "end_day" : -2621, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-038", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 12, "end_day" : 96, "on_study" : { "$date" : "2013-08-28T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc1" }, "patient_id" : "qaAHuhPpzpmtubAt8", "patient_label" : "DTB-039", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-039", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1436, "end_day" : 104, "reason_for_stop" : "Patient Demise" }, { "drug_name" : "Casodex", "start_day" : -987, "end_day" : -909, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Panobinostat", "start_day" : -849, "end_day" : -765, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -722, "end_day" : -121, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Taxotere", "start_day" : -115, "end_day" : 5, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-039", "drug_name" : "Docetaxel;  Phenelzine", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : 104, "on_study" : { "$date" : "2013-09-11T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc2" }, "patient_id" : "GGhtvTho3C3g2xYbu", "patient_label" : "DTB-040", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 57, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-040", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AURKB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHEK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -119, "end_day" : -99, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -105, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -20, "end_day" : -12, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-040", "drug_name" : "Cisplatin; Etoposide", "treatment_category" : "SOC", "start_day" : 6, "end_day" : 118, "on_study" : { "$date" : "2013-09-10T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc3" }, "patient_id" : "ps8mqWJ96qF8ezHQC", "patient_label" : "DTB-041", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-041", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -3176, "end_day" : -2446, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -681, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -688, "end_day" : -658, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -3176, "end_day" : -2446, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-041", "drug_name" : "Abiraterone", "treatment_category" : "Clinical Trial", "start_day" : 19, "end_day" : NaN, "on_study" : { "$date" : "2013-09-11T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc4" }, "patient_id" : "MCxa44g7oM7yxYcEw", "patient_label" : "DTB-042", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 64, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-042", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex;  Casodex", "start_day" : -2068, "end_day" : -1762, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -759, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -348, "end_day" : -149, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Cabazitaxel", "start_day" : -76, "end_day" : -76, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -598, "end_day" : -456, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -98, "end_day" : -89, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-042", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 1, "end_day" : NaN, "on_study" : { "$date" : "2013-10-28T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc5" }, "patient_id" : "DSRzC4LZsWE3EXsay", "patient_label" : "DTB-043", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 55, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-043", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Finasteride", "start_day" : -616, "end_day" : -232, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -616, "end_day" : -212, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -226, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-043", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 6, "end_day" : 23, "on_study" : { "$date" : "2013-10-15T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc6" }, "patient_id" : "4f2AGwwXFmS5drMu8", "patient_label" : "DTB-044", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 72, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-044", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Docetaxel", "start_day" : -486, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Carboplatin; Taxol", "start_day" : -406, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -277, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -214, "end_day" : NaN, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-044", "drug_name" : "CC-115", "treatment_category" : "Clinical Trial", "start_day" : 44, "end_day" : 86, "on_study" : { "$date" : "2013-10-27T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc7" }, "patient_id" : "z4P6GjrZfbBDwTkRE", "patient_label" : "DTB-045", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-045", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron;  Casodex", "start_day" : -503, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Taxotere", "start_day" : -161, "end_day" : -98, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-045", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 42, "end_day" : 121, "on_study" : { "$date" : "2013-10-02T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-045", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 149, "end_day" : 210, "on_study" : { "$date" : "2013-10-02T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Adverse Event" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc8" }, "patient_id" : "RZfyq5pqAGyfhLhjv", "patient_label" : "DTB-046", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-046", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "SRC_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Docetaxel", "start_day" : -718, "end_day" : -718, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Abiraterone", "start_day" : -547, "end_day" : 230, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -1097, "end_day" : -813, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : NaN, "end_day" : -957, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-046", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 236, "end_day" : 530, "on_study" : { "$date" : "2013-10-21T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dc9" }, "patient_id" : "9WT8s8KxXhKheXCDy", "patient_label" : "DTB-047", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 73, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-047", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -3029, "end_day" : -3029, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -2572, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1690, "end_day" : -1430, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Placebo", "start_day" : -1372, "end_day" : -1325, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -1253, "end_day" : -1019, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -981, "end_day" : -472, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -420, "end_day" : -161, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Cabazitaxel", "start_day" : -126, "end_day" : 63, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-047", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 108, "end_day" : 264, "on_study" : { "$date" : "2013-10-15T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dca" }, "patient_id" : "MyZqz9gJt7fRqAG6a", "patient_label" : "DTB-049", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 69, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-049", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCG_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCD_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2828, "end_day" : -1977, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1398, "end_day" : -1186, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1339, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -943, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -608, "end_day" : -562, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -489, "end_day" : -433, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Carboplatin;  Taxotere", "start_day" : -296, "end_day" : -263, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -223, "end_day" : NaN, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -243, "end_day" : 1, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-049", "drug_name" : "Docetaxel;  Carboplatin", "treatment_category" : "SOC", "start_day" : 19, "end_day" : 124, "on_study" : { "$date" : "2013-10-29T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dcb" }, "patient_id" : "Ck3AXxRFChxMuAXeE", "patient_label" : "DTB-050", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 67, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-050", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -4327, "end_day" : -4327, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : -1311, "end_day" : -618, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Lupron", "start_day" : -611, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -589, "end_day" : -456, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -370, "end_day" : -250, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -201, "end_day" : -20, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-050", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2013-11-05T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dcc" }, "patient_id" : "fuSFmqY9comJzGnbB", "patient_label" : "DTB-052", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 67, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-052", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -4760, "end_day" : -4091, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -3217, "end_day" : -2357, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -3179, "end_day" : -3179, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -957, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -965, "end_day" : -538, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -461, "end_day" : -432, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -272, "end_day" : 1, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-052", "drug_name" : "Mitoxantrone;  Dexamethasone;  Cabazitaxel", "treatment_category" : "Clinical Trial", "start_day" : 29, "end_day" : 71, "on_study" : { "$date" : "2013-11-12T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dcd" }, "patient_id" : "FFL2hnhAnZXpA23LY", "patient_label" : "DTB-053", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-053", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK7_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -1059, "end_day" : -878, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -542, "end_day" : -512, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -542, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -311, "end_day" : -192, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -211, "end_day" : -211, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Taxotere;  Carboplatin", "start_day" : -147, "end_day" : -35, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-053", "drug_name" : "Xofigo;  Enzalutamide", "treatment_category" : "SOC", "start_day" : 1, "end_day" : 32, "on_study" : { "$date" : "2013-11-24T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Physician Discretion" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dce" }, "patient_id" : "hnZ8xTPSpuJZHydH3", "patient_label" : "DTB-055", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 75, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-055", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-055Pro", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -1316, "end_day" : -1133, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Zoladex", "start_day" : -829, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -645, "end_day" : -190, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -190, "end_day" : -70, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -190, "end_day" : -190, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ketoconazole", "start_day" : -3, "end_day" : -3, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -757, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-055Pro", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 55, "end_day" : 114, "on_study" : { "$date" : "2013-11-06T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-055Pro", "drug_name" : "Ketoconazole", "treatment_category" : "SOC", "start_day" : 12, "end_day" : 56, "on_study" : { "$date" : "2013-11-06T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-055Pro", "drug_name" : { "$undefined" : true }, "treatment_category" : "SOC", "start_day" : 176, "end_day" : 176, "on_study" : { "$date" : "2013-11-06T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-055Pro", "drug_name" : { "$undefined" : true }, "treatment_category" : "SOC", "start_day" : 196, "end_day" : 210, "on_study" : { "$date" : "2013-11-06T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dcf" }, "patient_id" : "Y8FJEXSi7NXhEBK7y", "patient_label" : "DTB-056", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 72, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-056", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2501, "end_day" : -2501, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -1770, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1770, "end_day" : -1739, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -675, "end_day" : -603, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -497, "end_day" : -340, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Enzalutamide", "start_day" : -560, "end_day" : -523, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-056", "drug_name" : "Cabazitaxel;  Custirsen", "treatment_category" : "SOC", "start_day" : 96, "end_day" : 188, "on_study" : { "$date" : "2013-11-05T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-056", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 225, "end_day" : 399, "on_study" : { "$date" : "2013-11-05T16:00:00.000-0800" }, "psa_response" : "30%-50%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-056", "drug_name" : "Cyclophosphamide;  Dexamethasone", "treatment_category" : "SOC", "start_day" : 409, "end_day" : 480, "on_study" : { "$date" : "2013-11-05T16:00:00.000-0800" }, "psa_response" : "0%-30%", "bone_response" : "N/A", "reason_for_stop" : "Other" }, { "sample_label" : "DTB-056", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 502, "end_day" : 506, "on_study" : { "$date" : "2013-11-05T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-056", "drug_name" : { "$undefined" : true }, "treatment_category" : "SOC", "start_day" : 422, "end_day" : 429, "on_study" : { "$date" : "2013-11-05T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd0" }, "patient_id" : "XH4NiATpeS2f5L3gZ", "patient_label" : "DTB-057", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 65, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-057", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2151, "end_day" : -2151, "reason_for_stop" : "Adverse Event" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1754, "end_day" : -1300, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Casodex", "start_day" : -1212, "end_day" : -626, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Lupron", "start_day" : -1212, "end_day" : -1212, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Zoladex", "start_day" : -759, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -129, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-057", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 63, "end_day" : 189, "on_study" : { "$date" : "2013-11-20T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-057", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 228, "end_day" : NaN, "on_study" : { "$date" : "2013-11-20T16:00:00.000-0800" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd1" }, "patient_id" : "tEWyTP24pwHoLwjrX", "patient_label" : "DTB-058", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-058", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -1573, "end_day" : -1531, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Docetaxel", "start_day" : -1316, "end_day" : -1181, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Leuprolide", "start_day" : -1316, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -845, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Nilutamide", "start_day" : -763, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -554, "end_day" : -341, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -330, "end_day" : -210, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -330, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -210, "end_day" : -146, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -110, "end_day" : -12, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -82, "end_day" : -76, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-058", "drug_name" : "Mitoxantrone", "treatment_category" : { "$undefined" : true }, "start_day" : 9, "end_day" : 115, "on_study" : { "$date" : "2013-12-02T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd2" }, "patient_id" : "JN2YvC2f2srJCGEpP", "patient_label" : "DTB-059", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 64, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-059", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK7_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AURKA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -1326, "end_day" : -1326, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -1190, "end_day" : -994, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "start_day" : -3673, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Goserelin", "start_day" : -3673, "end_day" : -3016, "reason_for_stop" : "Other" }, { "drug_name" : "Bicalutamide", "start_day" : -2925, "end_day" : -2357, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -480, "end_day" : -398, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Mitoxantrone", "start_day" : -347, "end_day" : -158, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Cabozantinib", "start_day" : -1078, "end_day" : -12, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Leuprolide", "start_day" : -2925, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -599, "end_day" : -500, "reason_for_stop" : "Adverse Event" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1271, "end_day" : -1265, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -831, "end_day" : -831, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -815, "end_day" : -815, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -777, "end_day" : -766, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -634, "end_day" : -628, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -129, "end_day" : -123, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1193, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-059", "drug_name" : "Enzalutamide", "treatment_category" : { "$undefined" : true }, "start_day" : 9, "end_day" : 150, "on_study" : { "$date" : "2013-12-01T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd3" }, "patient_id" : "ZGmugdjYd3jrHFtGa", "patient_label" : "DTB-060", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 82, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-060", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AKT1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKD1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKCD_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-060Pro", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -3982, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -3982, "end_day" : -1309, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -1183, "end_day" : -874, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Dasatinib", "start_day" : -1091, "end_day" : -874, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Panobinostat", "start_day" : -560, "end_day" : -476, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -560, "end_day" : -462, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -461, "end_day" : -14, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-060Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 15, "end_day" : 458, "on_study" : { "$date" : "2013-11-25T16:00:00.000-0800" }, "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd4" }, "patient_id" : "4AnJj8QDgAdWgAPdJ", "patient_label" : "DTB-061", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "Asian", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-061", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "STK11_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "start_day" : -483, "end_day" : -368, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Goserelin", "start_day" : -483, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -203, "end_day" : -41, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -33, "end_day" : -3, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -211, "end_day" : -205, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -127, "end_day" : -127, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -96, "end_day" : -96, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -42, "end_day" : -35, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-061", "drug_name" : "Docetaxel", "treatment_category" : { "$undefined" : true }, "start_day" : 26, "end_day" : 119, "on_study" : { "$date" : "2013-12-03T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Patient Demise" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd5" }, "patient_id" : "6x6ripT4CYxZMjngF", "patient_label" : "DTB-062", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-062", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -821, "end_day" : -821, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -720, "end_day" : -666, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Zoladex", "start_day" : -660, "end_day" : -471, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -660, "end_day" : -598, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -335, "end_day" : -317, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -289, "end_day" : -323, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -158, "end_day" : -50, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -292, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-062", "drug_name" : "Docetaxel", "treatment_category" : "SOC", "start_day" : 30, "end_day" : 175, "on_study" : { "$date" : "2013-11-19T16:00:00.000-0800" }, "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-062", "drug_name" : "Radium-223 chloride", "treatment_category" : "SOC", "start_day" : 188, "end_day" : 315, "on_study" : { "$date" : "2013-11-19T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-062", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 329, "end_day" : 376, "on_study" : { "$date" : "2013-11-19T16:00:00.000-0800" }, "psa_response" : "0%-30%", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd6" }, "patient_id" : "Fi7nomepsaH8hTFsh", "patient_label" : "DTB-063", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 65, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-063", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PDPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPKAPK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-063Pro", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1821, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1821, "end_day" : -57, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1737, "end_day" : -1680, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-063Pro", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : 55, "end_day" : 349, "on_study" : { "$date" : "2013-12-11T16:00:00.000-0800" }, "psa_response" : "50%-90%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-063Pro", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 416, "end_day" : NaN, "on_study" : { "$date" : "2013-12-11T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-063Pro", "drug_name" : "MEK-162", "treatment_category" : "Clinical Trial", "start_day" : 383, "end_day" : 413, "on_study" : { "$date" : "2013-12-11T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-063Pro", "drug_name" : "Provenge", "treatment_category" : "SOC", "start_day" : 25, "end_day" : 56, "on_study" : { "$date" : "2013-12-11T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-063Pro", "drug_name" : { "$undefined" : true }, "treatment_category" : "SOC", "start_day" : 63, "end_day" : 91, "on_study" : { "$date" : "2013-12-11T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd7" }, "patient_id" : "vuAQjatrvhjj36WvK", "patient_label" : "DTB-064", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 62, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-064", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CSNK2A1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -3358, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -2993, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -2689, "end_day" : -2324, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -2171, "end_day" : -4668, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Estrogen", "start_day" : -924, "end_day" : -832, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -744, "end_day" : -589, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -193, "end_day" : -23, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-064", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : 385, "on_study" : { "$date" : "2013-12-10T16:00:00.000-0800" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd8" }, "patient_id" : "8asdquHwRJMxJumT9", "patient_label" : "DTB-065", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 69, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-065", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex", "start_day" : -2268, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -2042, "end_day" : -1506, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -2268, "end_day" : -1432, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Vandetanib", "start_day" : -1385, "end_day" : -1301, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -1385, "end_day" : -1301, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "OGX-427", "start_day" : -1216, "end_day" : -1007, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Docetaxel", "start_day" : -1209, "end_day" : -1021, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -927, "end_day" : -843, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -784, "end_day" : -447, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -784, "end_day" : -448, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -426, "end_day" : -257, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -1810, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Enzalutamide", "start_day" : -221, "end_day" : -95, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Mitoxantrone", "start_day" : -81, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1981, "end_day" : -1939, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1231, "end_day" : -1231, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -900, "end_day" : -900, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -738, "end_day" : -731, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -507, "end_day" : -522, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -507, "end_day" : -501, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -238, "end_day" : -238, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -83, "end_day" : -83, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -405, "end_day" : -405, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-065", "drug_name" : "Mitoxantrone", "treatment_category" : { "$undefined" : true }, "start_day" : -81, "end_day" : 59, "on_study" : { "$date" : "2013-12-15T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dd9" }, "patient_id" : "PTX2wabKo4E3ewmam", "patient_label" : "DTB-067", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 73, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-067", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-067Pro", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -4496, "end_day" : -4440, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -1855, "end_day" : -1791, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : -1834, "end_day" : -1645, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1211, "end_day" : -1001, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : -1197, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -972, "end_day" : -119, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "RAD001", "start_day" : -972, "end_day" : -119, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -84, "end_day" : 63, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-067Pro", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 135, "end_day" : 216, "on_study" : { "$date" : "2013-11-26T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dda" }, "patient_id" : "RbbW8TWQRFr6nyp9G", "patient_label" : "DTB-068", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 70, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-068", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -2128, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -2128, "end_day" : -2114, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -2025, "end_day" : -1972, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -1661, "end_day" : -593, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilutamide", "start_day" : -461, "end_day" : -268, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Provenge", "start_day" : -349, "end_day" : -321, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -209, "end_day" : -31, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-068", "drug_name" : "Itraconazole", "treatment_category" : "SOC", "start_day" : 78, "end_day" : 99, "on_study" : { "$date" : "2014-01-07T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-068", "drug_name" : "Docetaxel;  Carboplatin", "treatment_category" : "SOC", "start_day" : 110, "end_day" : 201, "on_study" : { "$date" : "2014-01-07T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011ddb" }, "patient_id" : "ajdqZZuLLQBqhniwY", "patient_label" : "DTB-069", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 73, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-069", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPKAPK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Flutamide", "start_day" : -1389, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : -1381, "end_day" : -526, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "OGX-427", "start_day" : -650, "end_day" : -420, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -703, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -367, "end_day" : -174, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Reolysin", "start_day" : -367, "end_day" : -174, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Enzalutamide", "start_day" : -86, "end_day" : 33, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Cabazitaxel", "start_day" : 34, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-069", "drug_name" : "Cabazitaxel", "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : 169, "on_study" : { "$date" : "2013-12-18T16:00:00.000-0800" }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011ddc" }, "patient_id" : "zmJQPBJGHjx4Mrf4H", "patient_label" : "DTB-070", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 76, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-070", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : NaN, "end_day" : -732, "reason_for_stop" : "Patient Choice" }, { "drug_name" : { "$undefined" : true }, "start_day" : -746, "end_day" : -697, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -360, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -391, "end_day" : -35, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-070", "drug_name" : "Radium-223 chloride", "treatment_category" : "SOC", "start_day" : 114, "end_day" : 179, "on_study" : { "$date" : "2014-01-26T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PR", "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011ddd" }, "patient_id" : "Qf22huSRfLFtTKdkN", "patient_label" : "DTB-071", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-071", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AURKB_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHEK2_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Flutamide", "start_day" : -3580, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : "Zoladex", "start_day" : -3566, "end_day" : -663, "reason_for_stop" : "Other" }, { "drug_name" : "Casodex", "start_day" : -910, "end_day" : -761, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Leuprolide", "start_day" : -663, "end_day" : -119, "reason_for_stop" : "Other" }, { "drug_name" : "Nilutamide", "start_day" : -655, "end_day" : -453, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -453, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -761, "end_day" : -655, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-071", "drug_name" : "Abiraterone", "treatment_category" : { "$undefined" : true }, "start_day" : 154, "end_day" : 210, "on_study" : { "$date" : "2014-01-05T16:00:00.000-0800" }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dde" }, "patient_id" : "WHhmzQkpYaYPRPmx9", "patient_label" : "DTB-072", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-072", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2215, "end_day" : -1193, "reason_for_stop" : "Other" }, { "drug_name" : { "$undefined" : true }, "start_day" : -2033, "end_day" : -1515, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1515, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1193, "end_day" : NaN, "reason_for_stop" : "Other" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1160, "end_day" : -960, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -903, "end_day" : NaN, "reason_for_stop" : "Other" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011ddf" }, "patient_id" : "hSm7skpwp8KJ37N6y", "patient_label" : "DTB-073", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-073", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AKT1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PDPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-073Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AKT1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MTOR_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1579, "end_day" : -1214, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Lupron", "start_day" : -1002, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1609, "end_day" : -1487, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1032, "end_day" : -544, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -489, "end_day" : -12, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-073Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 3, "end_day" : 60, "on_study" : { "$date" : "2014-01-26T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de0" }, "patient_id" : "KauTvtzwMmdywiRaM", "patient_label" : "DTB-074", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 76, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-074", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -5505, "end_day" : -5505, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Goserelin", "start_day" : -4531, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ketoconazole;  Hydrocortisone Sodium Succinate", "start_day" : -2127, "end_day" : -196, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -196, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Goserelin", "start_day" : -2120, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-074", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-01-26T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de1" }, "patient_id" : "fLjeCZbAQ6HnmrAYb", "patient_label" : "DTB-075", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 71, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-075", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -857, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -857, "end_day" : -674, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -430, "end_day" : -340, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -335, "end_day" : -287, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Enzalutamide", "start_day" : -264, "end_day" : -223, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Sipuleucel-T", "start_day" : -279, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -221, "end_day" : -116, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Xofigo", "start_day" : -84, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -30, "end_day" : NaN, "reason_for_stop" : "Patient Demise" }, { "sample_label" : "DTB-075", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-02-03T16:00:00.000-0800" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de2" }, "patient_id" : "EzFRr9yo6xhFiLxuj", "patient_label" : "DTB-076", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 79, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-076", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -5167, "end_day" : -4792, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Bicalutamide", "start_day" : -5167, "end_day" : -5006, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : { "$undefined" : true }, "start_day" : -4792, "end_day" : -4427, "reason_for_stop" : "Other" }, { "drug_name" : { "$undefined" : true }, "start_day" : -4031, "end_day" : -3331, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -3280, "end_day" : -3056, "reason_for_stop" : "Adverse Event" }, { "drug_name" : { "$undefined" : true }, "start_day" : -3241, "end_day" : -2935, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -2054, "end_day" : -1839, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -2054, "end_day" : -2023, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Nilutamide", "start_day" : -1723, "end_day" : -1401, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -1807, "end_day" : -1723, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1627, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "start_day" : -1117, "end_day" : -1081, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1044, "end_day" : -775, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -775, "end_day" : -593, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -497, "end_day" : -316, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -295, "end_day" : -1, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-076", "drug_name" : "Docetaxel", "treatment_category" : { "$undefined" : true }, "start_day" : 12, "end_day" : 107, "on_study" : { "$date" : "2014-02-13T16:00:00.000-0800" }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de3" }, "patient_id" : "Qj96pr8FM7Q7rHTDc", "patient_label" : "DTB-077", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 70, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-077", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1098, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -435, "end_day" : -60, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -2600, "end_day" : -2600, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-077", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 8, "end_day" : NaN, "on_study" : { "$date" : "2014-02-12T16:00:00.000-0800" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de4" }, "patient_id" : "jXTBoA2w7pGFbJWao", "patient_label" : "DTB-078", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 89, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-078", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1024, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -1024, "end_day" : -901, "reason_for_stop" : "Other" }, { "drug_name" : "Abiraterone", "start_day" : -871, "end_day" : -810, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -104, "end_day" : -43, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-078", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : 20, "end_day" : 48, "on_study" : { "$date" : "2014-02-17T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de5" }, "patient_id" : "ia6n9gAnqSzxyrw9C", "patient_label" : "DTB-079", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 78, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-079", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -4229, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1550, "end_day" : -1466, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -1445, "end_day" : -1193, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole", "start_day" : -1193, "end_day" : -10, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-079", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 16, "end_day" : 138, "on_study" : { "$date" : "2014-02-27T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de6" }, "patient_id" : "xPunswTDMyokxRfGK", "patient_label" : "DTB-080", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 59, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-080", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CAMK2A_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-080Pro", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "LCK_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CHUK_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -374, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-080Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 4, "end_day" : 275, "on_study" : { "$date" : "2014-03-06T16:00:00.000-0800" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de7" }, "patient_id" : "eFkcjhr24zkZ4xhgE", "patient_label" : "DTB-081", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 53, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-081", "site_of_metastasis" : "Liver", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -605, "end_day" : -288, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -861, "end_day" : -728, "reason_for_stop" : "Other" }, { "drug_name" : "Casodex", "start_day" : -919, "end_day" : -871, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1087, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Cabazitaxel", "start_day" : -124, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Custirsen", "start_day" : 233, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Enzalutamide", "start_day" : -292, "end_day" : -189, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "PX-866", "start_day" : -330, "end_day" : -288, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-081", "drug_name" : "Etoposide;  Cisplatin", "treatment_category" : { "$undefined" : true }, "start_day" : 168, "end_day" : 92, "on_study" : { "$date" : "2014-03-19T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de8" }, "patient_id" : "zqxoq7dZ8ocAzpMpr", "patient_label" : "DTB-082", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 62, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-082", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -947, "end_day" : 1, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -956, "end_day" : -949, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-082", "drug_name" : "Ipilimumab;  Provenge", "treatment_category" : "Clinical Trial", "start_day" : 36, "end_day" : 145, "on_study" : { "$date" : "2014-04-01T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011de9" }, "patient_id" : "eNjraYqeFYG4j8XMC", "patient_label" : "DTB-083", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 75, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-083", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "AKT1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKACA_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MTOR_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -2620, "end_day" : -2620, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : 21, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -155, "end_day" : -63, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -1889, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -1889, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -520, "end_day" : -338, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Taxotere", "start_day" : -794, "end_day" : -794, "reason_for_stop" : "Adverse Event" }, { "sample_label" : "DTB-083", "drug_name" : "Cabazitaxel", "treatment_category" : "Clinical Trial", "start_day" : 56, "end_day" : 146, "on_study" : { "$date" : "2014-03-04T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-083", "drug_name" : "Cytoxan", "treatment_category" : "SOC", "start_day" : 149, "end_day" : 196, "on_study" : { "$date" : "2014-03-04T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dea" }, "patient_id" : "njzpwxcbXrg9tat42", "patient_label" : "DTB-084", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 59, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-084", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1010, "end_day" : -625, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Abiraterone", "start_day" : -588, "end_day" : -16, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -2135, "end_day" : -2155, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Lupron", "start_day" : -1614, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-084", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 7, "end_day" : 145, "on_study" : { "$date" : "2014-04-02T17:00:00.000-0700" }, "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011deb" }, "patient_id" : "kBvHt9C9S8sD8A6wC", "patient_label" : "DTB-085", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 74, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-085", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "PRKAA1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -158, "end_day" : -151, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -89, "end_day" : -89, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -78, "end_day" : -74, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Finasteride", "start_day" : -2602, "end_day" : -2195, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1802, "end_day" : -1840, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Bicalutamide", "start_day" : -2167, "end_day" : -2136, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -1330, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -969, "end_day" : -791, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Bicalutamide", "start_day" : -1100, "end_day" : -1020, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "OGX-427", "start_day" : -774, "end_day" : 79, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Custirsen", "start_day" : -616, "end_day" : -404, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Docetaxel", "start_day" : -607, "end_day" : -385, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -607, "end_day" : -357, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -313, "end_day" : -251, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : { "$undefined" : true }, "start_day" : -313, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -245, "end_day" : -14, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-085", "drug_name" : "Docetaxel", "treatment_category" : { "$undefined" : true }, "start_day" : 2, "end_day" : 145, "on_study" : { "$date" : "2014-04-14T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dec" }, "patient_id" : "WBJ7PDG7iYMuuzZm8", "patient_label" : "DTB-087", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-087", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "start_day" : -1806, "end_day" : -1447, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -290, "end_day" : -128, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Degarelix", "start_day" : -1043, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -1806, "end_day" : -1430, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-087", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : NaN, "on_study" : { "$date" : "2014-04-16T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011ded" }, "patient_id" : "B52qpDonZWEffJYKN", "patient_label" : "DTB-092", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-092", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "start_day" : -1261, "end_day" : -1261, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -1259, "end_day" : -1227, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -366, "end_day" : -31, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1059, "end_day" : -896, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1039, "end_day" : -993, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -485, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-092", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 7, "end_day" : 138, "on_study" : { "$date" : "2014-05-14T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011dee" }, "patient_id" : "vMKaZCjPwEae2zyPo", "patient_label" : "DTB-093", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 73, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-093", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "sample_label" : "DTB-093", "drug_name" : { "$undefined" : true }, "treatment_category" : "Clinical Trial", "start_day" : 27, "end_day" : 85, "on_study" : { "$date" : "2014-05-26T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Physician Discretion" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011def" }, "patient_id" : "qG7ycnpJ4x5HbofSn", "patient_label" : "DTB-094", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 65, "race" : "Black or African American", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-094", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -906, "end_day" : 0, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Hydrocortisone Sodium Succinate;  Ketoconazole", "start_day" : -1689, "end_day" : -1227, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -1980, "end_day" : -1689, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Zoladex", "start_day" : -2142, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Zoladex", "start_day" : -2511, "end_day" : -2446, "reason_for_stop" : "Physician Discretion" }, { "drug_name" : "Lupron", "start_day" : NaN, "end_day" : -3090, "reason_for_stop" : "Other" }, { "drug_name" : "Docetaxel", "start_day" : -1230, "end_day" : -925, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-094", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : -30, "end_day" : 145, "on_study" : { "$date" : "2014-06-17T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Other" }, { "sample_label" : "DTB-094", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-06-17T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df0" }, "patient_id" : "BQReq3RgPDwKhwYyg", "patient_label" : "DTB-095", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 67, "race" : "Unknown", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-095", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "RPS6KA3_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "CDK9_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] }, { "sample_label" : "DTB-095Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Trelstar", "start_day" : -2705, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -1823, "end_day" : -1701, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -1154, "end_day" : -454, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Denosumab", "start_day" : -940, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -423, "end_day" : -270, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Xofigo", "start_day" : -190, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -135, "end_day" : NaN, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-095Pro", "drug_name" : "Provenge", "treatment_category" : "SOC", "start_day" : 32, "end_day" : 74, "on_study" : { "$date" : "2014-05-28T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df1" }, "patient_id" : "CMbtx53M6bSAbC6vT", "patient_label" : "DTB-096", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 70, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-096", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] }, { "sample_label" : "DTB-096Pro", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -332, "end_day" : -16, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -727, "end_day" : -637, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -1336, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1305, "end_day" : -879, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-096Pro", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 5, "end_day" : 130, "on_study" : { "$date" : "2014-05-28T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df2" }, "patient_id" : "yDd9Y5XoaCiCS4829", "patient_label" : "DTB-098", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 58, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-098", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -199, "end_day" : -171, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Casodex", "start_day" : -219, "end_day" : -209, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Lupron", "start_day" : -202, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Degarelix", "start_day" : -233, "end_day" : -233, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-098", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 6, "end_day" : NaN, "on_study" : { "$date" : "2014-05-28T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df3" }, "patient_id" : "FirSTzzFCnc5XDKin", "patient_label" : "DTB-099", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-099", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -540, "end_day" : -24, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -862, "end_day" : -582, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -1568, "end_day" : -1291, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Lupron", "start_day" : -3425, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -6731, "end_day" : -6731, "reason_for_stop" : "Completed Treatment" }, { "sample_label" : "DTB-099", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 4, "end_day" : NaN, "on_study" : { "$date" : "2014-06-05T17:00:00.000-0700" }, "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df4" }, "patient_id" : "KyTrhrKpaTdYBHZ72", "patient_label" : "DTB-100", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "treatments" : [ { "drug_name" : "Casodex", "start_day" : -6142, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -1311, "end_day" : -1226, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -605, "end_day" : -423, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -1088, "end_day" : -635, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Degarelix", "start_day" : -1078, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "start_day" : -1697, "end_day" : -1486, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Goserelin", "start_day" : -3552, "end_day" : -1161, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "start_day" : -4396, "end_day" : -5116, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Goserelin", "start_day" : -4396, "end_day" : -4386, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "start_day" : -3548, "end_day" : -3284, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Goserelin", "start_day" : -6142, "end_day" : -6053, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Bicalutamide", "start_day" : -3254, "end_day" : -2060, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -5126, "end_day" : -5082, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1088, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1955, "end_day" : -1428, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-100", "drug_name" : "Mitoxantrone", "treatment_category" : { "$undefined" : true }, "start_day" : 6, "end_day" : 29, "on_study" : { "$date" : "2014-06-11T17:00:00.000-0700" }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df5" }, "patient_id" : "ZNPG2urzb9gqdbE7q", "patient_label" : "DTB-102", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 85, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-102", "site_of_metastasis" : "Other", "procedure_day" : 3, "signatures" : [ { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "MAPK1_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATM_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 }, { "type" : "kinase", "description" : "Kinase Activation", "signatures" : [ { "signature_algorithm_label" : "ATR_kinase_viper_v4", "value_type" : "kinase_viper", "individual_signatures" : [ { "signature_label" : "PLK1_kinase_viper", "patient_values_in_cohort" : [ { "patient_label" : "DTB-001", "value" : 1 }, { "patient_label" : "DTB-003", "value" : 3 }, { "patient_label" : "DTB-069", "value" : 30 }, { "patient_label" : "DTB-011", "value" : 20 }, { "patient_label" : "DTB-110", "value" : 21 } ] } ] } ], "job_id" : "j3j3j3i434343uf", "version_number" : 1 } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Provenge", "start_day" : -4438, "end_day" : -4410, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Ketoconazole", "start_day" : -2108, "end_day" : -1786, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Casodex", "start_day" : -2820, "end_day" : -2168, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Lupron", "start_day" : -4551, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Taxotere", "start_day" : -1772, "end_day" : -1667, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Abiraterone", "start_day" : -1093, "end_day" : -930, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Panobinostat", "start_day" : -631, "end_day" : -526, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Custirsen", "start_day" : -372, "end_day" : -217, "reason_for_stop" : "Patient Choice" }, { "drug_name" : "Casodex", "start_day" : -631, "end_day" : -526, "reason_for_stop" : "Adverse Event" }, { "drug_name" : "Provenge", "start_day" : -769, "end_day" : -733, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : { "$undefined" : true }, "start_day" : -6226, "end_day" : -6165, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Cabazitaxel", "start_day" : NaN, "end_day" : -232, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-102", "drug_name" : "Enzalutamide", "treatment_category" : "Clinical Trial", "start_day" : 8, "end_day" : NaN, "on_study" : { "$date" : "2014-06-17T17:00:00.000-0700" }, "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df6" }, "patient_id" : "WBHut669gk9sT23CN", "patient_label" : "DTB-104", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 82, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-104", "site_of_metastasis" : "Lymph nodes", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "start_day" : -1386, "end_day" : -1188, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ketoconazole", "start_day" : -1597, "end_day" : -997, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Ketoconazole", "start_day" : -6914, "end_day" : -6809, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "start_day" : -454, "end_day" : 152, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "start_day" : -869, "end_day" : -702, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Nilandron", "start_day" : -3631, "end_day" : -2372, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -3631, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "start_day" : -6818, "end_day" : -3631, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "start_day" : -7177, "end_day" : -7134, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-104", "drug_name" : "Abiraterone", "treatment_category" : "SOC", "start_day" : 163, "end_day" : 218, "on_study" : { "$date" : "2014-07-01T17:00:00.000-0700" }, "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df7" }, "patient_id" : "EeeHz587M8MSu5n6x", "patient_label" : "DTB-106", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 63, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-106", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "sample_label" : "DTB-106", "drug_name" : "Enzalutamide", "treatment_category" : "SOC", "start_day" : -180, "end_day" : 79, "on_study" : { "$date" : "2014-06-29T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease" }, { "sample_label" : "DTB-106", "drug_name" : "Xofigo", "treatment_category" : "SOC", "start_day" : -110, "end_day" : 53, "on_study" : { "$date" : "2014-06-29T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment" } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df8" }, "patient_id" : "m7kxAnxBNCMyvAMQM", "patient_label" : "DTB-107", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-107", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Goserelin", "start_day" : -5156, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -1572, "end_day" : -1559, "reason_for_stop" : "Completed Treatment" }, { "drug_name" : "Abiraterone", "start_day" : -1200, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Nilutamide", "start_day" : -1953, "end_day" : -1246, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Ketoconazole;  Hydrocortisone Sodium Succinate", "start_day" : -2687, "end_day" : -1953, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Flutamide", "start_day" : -2800, "end_day" : -2730, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Docetaxel", "start_day" : -3146, "end_day" : -3048, "reason_for_stop" : "Patient Choice" }, { "sample_label" : "DTB-107", "drug_name" : { "$undefined" : true }, "treatment_category" : { "$undefined" : true }, "start_day" : NaN, "end_day" : NaN, "on_study" : { "$date" : "2014-06-29T17:00:00.000-0700" }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "559ed7e5a8e4fc1a63011df9" }, "patient_id" : "LfkqKXFT5vTYkAzsM", "patient_label" : "DTB-140", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "viewed" : true, "created_at" : "Thu Jul 09 2015 13:21:57 GMT-0700 (PDT)", "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-140", "site_of_metastasis" : "Bone", "procedure_day" : 3, "signatures" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "start_day" : -177, "end_day" : -23, "reason_for_stop" : "Progressive Disease" }, { "drug_name" : "Sipuleucel-T", "start_day" : -244, "end_day" : -221, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -359, "end_day" : NaN, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Degarelix", "start_day" : -398, "end_day" : -356, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Lupron", "start_day" : -465, "end_day" : -402, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "start_day" : -3237, "end_day" : -3143, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex;  Lupron", "start_day" : -3088, "end_day" : -482, "reason_for_stop" : { "$undefined" : true } }, { "sample_label" : "DTB-140", "drug_name" : "Selinexor", "treatment_category" : "Clinical Trial", "start_day" : 18, "end_day" : 82, "on_study" : { "$date" : "2015-01-07T16:00:00.000-0800" }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice" } ] }
